These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8383206)

  • 1. The genetics of malignant hyperthermia.
    Ball SP; Johnson KJ
    J Med Genet; 1993 Feb; 30(2):89-93. PubMed ID: 8383206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic basis of malignant hyperthermia.
    Moochhala SM; Tan WT; Lee TL
    Ann Acad Med Singap; 1994 Jul; 23(4):475-8. PubMed ID: 7979121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What significance to genotype changes have in diagnosis of malignant hyperthermia?].
    Steinfath M; Scholz J; Singh S; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Aug; 31(6):334-43. PubMed ID: 8962927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia--a large kindred linked to the RYR1 gene.
    Wallace AJ; Wooldridge W; Kingston HM; Harrison MJ; Ellis FR; Ford PM
    Anaesthesia; 1996 Jan; 51(1):16-23. PubMed ID: 8669559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multipoint mapping of the central core disease locus.
    Schwemmle S; Wolff K; Palmucci LM; Grimm T; Lehmann-Horn F; Hübner C; Hauser E; Iles DE; MacLennan DH; Müller CR
    Genomics; 1993 Jul; 17(1):205-7. PubMed ID: 8406450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic mapping of the beta 1- and gamma-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility.
    Iles DE; Segers B; Sengers RC; Monsieurs K; Heytens L; Halsall PJ; Hopkins PM; Ellis FR; Hall-Curran JL; Stewart AD
    Hum Mol Genet; 1993 Jul; 2(7):863-8. PubMed ID: 8395940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
    Muniz VP; Silva HC; Tsanaclis AM; Vainzof M
    J Mol Neurosci; 2003; 21(1):35-42. PubMed ID: 14500992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity and HOMOG analysis in British malignant hyperthermia families.
    Robinson R; Curran JL; Hall WJ; Halsall PJ; Hopkins PM; Markham AF; Stewart AD; West SP; Ellis FR
    J Med Genet; 1998 Mar; 35(3):196-201. PubMed ID: 9541102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of malignant hyperthermia.
    Brandom BW
    ScientificWorldJournal; 2006 Dec; 6():1722-30. PubMed ID: 17195870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic recombination between malignant hyperthermia and calcium release channel in skeletal muscle.
    Fagerlund T; Islander G; Ranklev E; Harbitz I; Hauge JG; Møkleby E; Berg K
    Clin Genet; 1992 May; 41(5):270-2. PubMed ID: 1318804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic linkage analysis of chromosome 19 markers in malignant hyperthermia.
    Ball SP; Dorkins HR; Ellis FR; Hall JL; Halsall PJ; Hopkins PM; Mueller RF; Stewart AD
    Br J Anaesth; 1993 Jan; 70(1):70-5. PubMed ID: 8431338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of discordance between genotype and phenotype in a malignant hyperthermia family.
    Fortunato G; Carsana A; Tinto N; Brancadoro V; Canfora G; Salvatore F
    Eur J Hum Genet; 1999; 7(4):415-20. PubMed ID: 10352931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.
    MacLennan DH; Duff C; Zorzato F; Fujii J; Phillips M; Korneluk RG; Frodis W; Britt BA; Worton RG
    Nature; 1990 Feb; 343(6258):559-61. PubMed ID: 1967823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
    Monnier N; Lunardi J
    Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for genetic heterogeneity in malignant hyperthermia susceptibility.
    Levitt RC; Nouri N; Jedlicka AE; McKusick VA; Marks AR; Shutack JG; Fletcher JE; Rosenberg H; Meyers DA
    Genomics; 1991 Nov; 11(3):543-7. PubMed ID: 1774061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for linkage of the central core disease locus to the proximal long arm of human chromosome 19.
    Kausch K; Lehmann-Horn F; Janka M; Wieringa B; Grimm T; Müller CR
    Genomics; 1991 Jul; 10(3):765-9. PubMed ID: 1889818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the skeletal muscle ryanodine receptor gene in malignant hyperthermia.
    MacLennan DH; Otsu K; Fujii J; Zorzato F; Phillips MS; O'Brien PJ; Archibald AL; Britt BA; Gillard EF; Worton RG
    Symp Soc Exp Biol; 1992; 46():189-201. PubMed ID: 1341035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2.
    McCarthy TV; Healy JM; Heffron JJ; Lehane M; Deufel T; Lehmann-Horn F; Farrall M; Johnson K
    Nature; 1990 Feb; 343(6258):562-4. PubMed ID: 2300206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant hyperthermia].
    Ording H; Bendixen D
    Nord Med; 1992; 107(1):12-4. PubMed ID: 1310356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.
    Monnier N; Kozak-Ribbens G; Krivosic-Horber R; Nivoche Y; Qi D; Kraev N; Loke J; Sharma P; Tegazzin V; Figarella-Branger D; Roméro N; Mezin P; Bendahan D; Payen JF; Depret T; Maclennan DH; Lunardi J
    Hum Mutat; 2005 Nov; 26(5):413-25. PubMed ID: 16163667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.